{"disease":{"id":"cancer-of-the-breast","name":"cancer of the breast"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04895709","title":"A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":949,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03475953","title":"A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":747,"lead_sponsor_name":"Institut Bergonié","has_results":false},{"nct_id":"NCT06711939","title":"Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":515,"lead_sponsor_name":"Mitera Hospital","has_results":false},{"nct_id":"NCT06981208","title":"ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction","phase":"NA","overall_status":"RECRUITING","enrollment_count":410,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04569747","title":"A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":393,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04074720","title":"Prospective Breast Cancer Biospecimen Collection","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT01881230","title":"Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT07067138","title":"A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)","phase":"NA","overall_status":"RECRUITING","enrollment_count":175,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06749210","title":"DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05269381","title":"Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05972343","title":"COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07072728","title":"Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":87,"lead_sponsor_name":"Psyence Australia Pty Ltd","has_results":false},{"nct_id":"NCT05252390","title":"NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":82,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT05837455","title":"NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":81,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02462200","title":"Shave Margins in Breast Conservation Therapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":81,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07277738","title":"Precision Supplemental Imaging in Women With Dense Breasts","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":78,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT00530868","title":"Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT04541225","title":"Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":74,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT03096054","title":"A CR-UK Phase I Trial of LY3143921","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":69,"lead_sponsor_name":"Cancer Research UK","has_results":false},{"nct_id":"NCT02913729","title":"Pre- Versus Postoperative Accelerated Partial Breast Irradiation","phase":"NA","overall_status":"TERMINATED","enrollment_count":65,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT04968964","title":"Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing","phase":"NA","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02476786","title":"Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03629756","title":"A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Arcus Biosciences, Inc.","has_results":false},{"nct_id":"NCT03740256","title":"Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT02595372","title":"Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Kathy Miller","has_results":true},{"nct_id":"NCT06595901","title":"Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05716542","title":"Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02891681","title":"Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT03652077","title":"A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT07512271","title":"Generative AI Patient Education Module for Breast Oncology","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03538028","title":"A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Incyte Biosciences International Sàrl","has_results":false},{"nct_id":"NCT02658708","title":"Bright Light on Fatigue in Women Being Treated for Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06471673","title":"A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"BriaCell Therapeutics Corporation","has_results":false},{"nct_id":"NCT02807597","title":"Real-time Intraoperative Breast Cancer Visualization for Margin Assessment","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Samuel Achilefu","has_results":true},{"nct_id":"NCT02669914","title":"MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Washington University School of Medicine","has_results":true}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}